Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

Advanced Science - Germany
doi 10.1002/advs.201900782
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Genome-Wide CRISPR/Cas9 Library Screening Identified PHGDH as a Critical Driver for Sorafenib Resistance in HCC

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Genome-Wide RNAi Screening Identifies TMIGD3 Isoform1 as a Suppressor of NF-κB and Osteosarcoma Progression

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Minimal Genome-Wide Human CRISPR-Cas9 Library

2019English

Genome-Scale CRISPR-Cas9 Knockout Screening in Gastrointestinal Stromal Tumor With Imatinib Resistance

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Application of CRISPR-Cas9 Based Genome-Wide Screening Approaches to Study Cellular Signalling Mechanisms

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Sulforaphane Reverses Chemo-Resistance to Temozolomide in Glioblastoma Cells by NF-κB-dependent Pathway Downregulating MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2015English

Genome-Wide CRISPR Analysis Identifies Substrate-Specific Conjugation Modules in ER-Associated Degradation

Molecular Cell
Cell BiologyMolecular Biology
2019English

Metabolic Targeting of EGFRvIII/PDK1 Axis in Temozolomide Resistant Glioblastoma

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy